tongue carcinoma (Cancer)
Information
- Disease name
- tongue carcinoma
- Disease ID
- DOID:0080641
- Description
- "A tongue cancer that derives_from epithelial cells that cover the surface of the tongue." [url:https\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=20.02d&ns=ncit&code=C4824&key=1996231099&b=1&n=null]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00588770 | Active, not recruiting | Phase 3 | Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | August 8, 2008 | February 22, 2025 |
NCT02254278 | Active, not recruiting | Phase 2 | Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer | October 2014 | May 31, 2025 |
NCT01175980 | Completed | Phase 2 | Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma | August 6, 2010 | August 1, 2018 |
NCT01254617 | Completed | Phase 1 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer | February 10, 2011 | January 29, 2014 |
NCT01256385 | Completed | Phase 2 | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy | November 2010 | December 2013 |
NCT02007200 | Completed | Phase 2 | Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery | July 2009 | September 2015 |
NCT00458978 | Completed | Phase 2 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | February 2007 | July 2014 |
NCT00594724 | Completed | N/A | Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging | November 2002 | June 2014 |
NCT04870762 | Recruiting | Phase 2 | Customized 3D Printed Oral Stents During Head and Neck Radiotherapy | May 26, 2021 | November 6, 2024 |
NCT02196168 | Terminated | Phase 2 | Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | March 2014 | April 2016 |
NCT02068157 | Terminated | Phase 2 | Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer | April 1, 2014 | November 4, 2016 |
- Disase is a (Disease Ontology)
- DOID:8649